TAVR in Cancer Patients: Comprehensive Review, Meta-Analysis, and Meta-Regression
Objectives: This study sought to systematically analyze the available clinical evidence on TAVR therapy in cancer patients with symptomatic severe AS.Background: Aortic stenosis is the most common valvular heart disease in the world. TAVR has expanded the treatment options for this lethal disease pr...
Main Authors: | Konstantinos Marmagkiolis, Dominique J. Monlezun, Mehmet Cilingiroglu, Cindy Grines, Joerg Herrmann, Konstantinos Pavlos Toutouzas, Ismail Ates, Cezar Iliescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.641268/full |
Similar Items
-
Clinical outcomes following transapical TAVR with ACURATE neo in the CHANGE neo TA study
by: Andreas Holzamer, et al.
Published: (2021-10-01) -
Current issues on simultaneous TAVR (Transcatheter Aortic Valve Replacement) and EVAR (Endovascular Aneurysm Repair)
by: Nikolaos Schizas, et al.
Published: (2021-07-01) -
Expansion of TAVR into Low-Risk Patients and Who to Consider for SAVR
by: Kunal V. Patel, et al.
Published: (2020-09-01) -
TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients
by: Dominique J. Monlezun, et al.
Published: (2021-06-01) -
Gender Differences after Transcatheter Aortic Valve Replacement (TAVR): Insights from the Italian Clinical Service Project
by: Andrea Denegri, et al.
Published: (2021-09-01)